Annual Total Liabilities
$38.49 M
+$8.98 M+30.43%
December 31, 2023
Summary
- As of February 7, 2025, FENC annual total liabilities is $38.49 million, with the most recent change of +$8.98 million (+30.43%) on December 31, 2023.
- During the last 3 years, FENC annual total liabilities has risen by +$36.14 million (+1539.80%).
- FENC annual total liabilities is now at all-time high.
Performance
FENC Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$64.09 M
-$426.00 K-0.66%
September 30, 2024
Summary
- As of February 7, 2025, FENC quarterly total liabilities is $64.09 million, with the most recent change of -$426.00 thousand (-0.66%) on September 30, 2024.
- Over the past year, FENC quarterly total liabilities has dropped by -$426.00 thousand (-0.66%).
- FENC quarterly total liabilities is now -3.15% below its all-time high of $66.18 million, reached on March 31, 2024.
Performance
FENC Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
FENC Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.4% | -0.7% |
| 3 y3 years | +1539.8% | +119.8% |
| 5 y5 years | +2251.0% | +119.8% |
FENC Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +479.4% | -3.1% | +867.4% |
| 5 y | 5-year | at high | +1594.7% | -3.1% | +3260.9% |
| alltime | all time | at high | +9473.6% | -3.1% | >+9999.0% |
Fennec Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $64.09 M(-0.7%) |
| Jun 2024 | - | $64.52 M(-2.5%) |
| Mar 2024 | - | $66.18 M(+72.0%) |
| Dec 2023 | $38.49 M(+30.4%) | $38.49 M(+30.2%) |
| Sep 2023 | - | $29.56 M(+1.4%) |
| Jun 2023 | - | $29.16 M(+0.0%) |
| Mar 2023 | - | $29.16 M(-1.2%) |
| Dec 2022 | $29.51 M(+344.3%) | $29.51 M(+6.9%) |
| Sep 2022 | - | $27.61 M(+293.0%) |
| Jun 2022 | - | $7.03 M(+6.1%) |
| Mar 2022 | - | $6.63 M(-0.3%) |
| Dec 2021 | $6.64 M(+183.0%) | $6.64 M(-5.1%) |
| Sep 2021 | - | $7.00 M(+20.0%) |
| Jun 2021 | - | $5.83 M(+101.7%) |
| Mar 2021 | - | $2.89 M(+23.2%) |
| Dec 2020 | $2.35 M(+3.3%) | $2.35 M(-18.6%) |
| Sep 2020 | - | $2.88 M(-9.6%) |
| Jun 2020 | - | $3.19 M(+67.3%) |
| Mar 2020 | - | $1.91 M(-16.0%) |
| Dec 2019 | $2.27 M(+38.7%) | $2.27 M(+150.9%) |
| Sep 2019 | - | $905.00 K(-33.1%) |
| Jun 2019 | - | $1.35 M(-6.8%) |
| Mar 2019 | - | $1.45 M(-11.4%) |
| Dec 2018 | $1.64 M(-0.4%) | $1.64 M(-21.1%) |
| Sep 2018 | - | $2.08 M(+145.1%) |
| Jun 2018 | - | $847.00 K(-27.8%) |
| Mar 2018 | - | $1.17 M(-28.6%) |
| Dec 2017 | $1.64 M(+309.0%) | $1.64 M(+59.6%) |
| Sep 2017 | - | $1.03 M(+77.6%) |
| Jun 2017 | - | $580.00 K(+35.8%) |
| Mar 2017 | - | $427.00 K(+6.2%) |
| Dec 2016 | $402.00 K(-14.6%) | $402.00 K(+11.7%) |
| Sep 2016 | - | $360.00 K(-20.2%) |
| Jun 2016 | - | $451.00 K(+30.7%) |
| Mar 2016 | - | $345.00 K(-26.8%) |
| Dec 2015 | $471.00 K(-73.2%) | $471.00 K(+9.3%) |
| Sep 2015 | - | $431.00 K(-43.2%) |
| Jun 2015 | - | $759.00 K(-32.4%) |
| Mar 2015 | - | $1.12 M(-36.2%) |
| Dec 2014 | $1.76 M(-45.2%) | $1.76 M(-54.9%) |
| Sep 2014 | - | $3.90 M(-31.6%) |
| Jun 2014 | - | $5.71 M(-0.4%) |
| Mar 2014 | - | $5.73 M(+78.6%) |
| Dec 2013 | $3.21 M(-56.2%) | $3.21 M(-32.7%) |
| Sep 2013 | - | $4.77 M(+37.8%) |
| Jun 2013 | - | $3.46 M(-68.6%) |
| Mar 2013 | - | $11.00 M(+50.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $7.32 M(+33.8%) | $7.32 M(+344.8%) |
| Sep 2012 | - | $1.65 M(+5.9%) |
| Jun 2012 | - | $1.55 M(-28.1%) |
| Mar 2012 | - | $2.16 M(-60.5%) |
| Dec 2011 | $5.47 M(-49.9%) | $5.47 M(-45.0%) |
| Sep 2011 | - | $9.94 M(+32.3%) |
| Jun 2011 | - | $7.51 M(-5.2%) |
| Mar 2011 | - | $7.92 M(-27.4%) |
| Dec 2010 | $10.92 M(+2456.7%) | $10.92 M(+118.4%) |
| Sep 2010 | - | $5.00 M(-34.5%) |
| Jun 2010 | - | $7.63 M(+1674.9%) |
| Mar 2010 | - | $430.00 K(+0.7%) |
| Dec 2009 | $427.00 K(-85.8%) | $427.00 K(-22.5%) |
| Sep 2009 | - | $551.00 K(-57.5%) |
| Jun 2009 | - | $1.30 M(-39.4%) |
| Mar 2009 | - | $2.14 M(-28.9%) |
| Dec 2008 | $3.01 M(-1.8%) | $3.01 M(-14.2%) |
| Sep 2008 | - | $3.50 M(+16.1%) |
| Jun 2008 | - | $3.02 M(-0.2%) |
| Mar 2008 | - | $3.03 M(-1.1%) |
| Dec 2007 | $3.06 M(-42.9%) | $3.06 M(+8.2%) |
| Sep 2007 | - | $2.83 M(+29.1%) |
| Jun 2007 | - | $2.19 M(-19.9%) |
| Mar 2007 | - | $2.74 M(-49.0%) |
| Dec 2006 | $5.36 M(-36.1%) | $5.36 M(-37.9%) |
| Sep 2006 | - | $8.63 M(+11.3%) |
| Jun 2006 | - | $7.75 M(-3.0%) |
| Mar 2006 | - | $7.99 M(-4.7%) |
| Dec 2005 | $8.39 M(-3.9%) | $8.39 M(-9.9%) |
| Sep 2005 | - | $9.31 M(-4.7%) |
| Jun 2005 | - | $9.77 M(+9.6%) |
| Mar 2005 | - | $8.92 M(+1.1%) |
| Sep 2004 | - | $8.82 M(+1.0%) |
| Jun 2004 | $8.73 M(-15.6%) | $8.73 M(+1.8%) |
| Mar 2004 | - | $8.58 M(-6.8%) |
| Dec 2003 | - | $9.20 M(-8.3%) |
| Sep 2003 | - | $10.03 M(-3.1%) |
| Jun 2003 | $10.35 M(+1304.0%) | $10.35 M(+24.6%) |
| Mar 2003 | - | $8.30 M(+2.9%) |
| Dec 2002 | - | $8.07 M(+718.4%) |
| Sep 2002 | - | $986.20 K(+33.8%) |
| Jun 2002 | $737.10 K(+16.0%) | $737.10 K(+28.8%) |
| Mar 2002 | - | $572.30 K(+8.6%) |
| Dec 2001 | - | $527.00 K(-3.1%) |
| Sep 2001 | - | $543.70 K(-14.4%) |
| Jun 2001 | $635.40 K(+6.5%) | $635.40 K(+19.3%) |
| Dec 2000 | - | $532.80 K |
| Jun 2000 | $596.50 K | - |
FAQ
- What is Fennec Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals annual total liabilities year-on-year change?
- What is Fennec Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals quarterly total liabilities year-on-year change?
What is Fennec Pharmaceuticals annual total liabilities?
The current annual total liabilities of FENC is $38.49 M
What is the all time high annual total liabilities for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high annual total liabilities is $38.49 M
What is Fennec Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, FENC annual total liabilities has changed by +$8.98 M (+30.43%)
What is Fennec Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of FENC is $64.09 M
What is the all time high quarterly total liabilities for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high quarterly total liabilities is $66.18 M
What is Fennec Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, FENC quarterly total liabilities has changed by -$426.00 K (-0.66%)